购物车
- 全部删除
- 您的购物车当前为空
HSD17B13-IN-31 (compound 32) 作为一种针对羟基类固醇17?-脱氢酶13 (HSD17B13)的有效抑制剂,其对雌二醇和白三烯 B3 的IC50值分别小于 0.1 μM 和 小于 1 μM。此化合物在非酒精性脂肪性肝炎(NASH)以及更广泛的非酒精性脂肪肝疾病(NAFLD)研究中具有显著的应用价值。
HSD17B13-IN-31 (compound 32) 作为一种针对羟基类固醇17?-脱氢酶13 (HSD17B13)的有效抑制剂,其对雌二醇和白三烯 B3 的IC50值分别小于 0.1 μM 和 小于 1 μM。此化合物在非酒精性脂肪性肝炎(NASH)以及更广泛的非酒精性脂肪肝疾病(NAFLD)研究中具有显著的应用价值。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | HSD17B13-IN-31 (compound 32) serves as a highly effective inhibitor of hydroxysteroid 17?-dehydrogenase 13 (HSD17B13), demonstrating an IC50 of less than 0.1 μM and less than 1 μM when using estradiol and Leukotriene B3 as substrates, respectively. This compound is critical in managing nonalcoholic fatty liver diseases (NAFLDs), including nonalcoholic steatohepatitis (NASH) [1]. |
分子量 | 465.35 |
分子式 | C21H18Cl2N2O4S |
CAS No. | 2758802-33-2 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
评论内容